Mendoza, Tito R.

Validity of the Brief Pain Inventory for Use in Documenting the Outcomes of Patients With Noncancer Pain

Keller, S., Bann, C. M., Dodd, S. L., Schein, J., Mendoza, T. R., & Cleeland, C. S. (2004) · The Clinical Journal of Pain

Musculoskeletal pain and rehabilitationPain Management and Opioid Use

Cited by 1,233

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Dueck, A. C., Mendoza, T. R., Mitchell, S. A., Reeve, B. B., Castro, K. M., Rogak, L. J., Atkinson, T. M., Bennett, A. V., Denicoff, A. M., O'Mara, A. M., et al. (2015) · JAMA Oncology

Cancer survivorship and careCancer-related cognitive impairment studies

Cited by 1,030

Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis

Mendoza, T., Mayne, T., Rublee, D., & Cleeland, C. (2006) · European Journal of Pain

Musculoskeletal pain and rehabilitationPain Management and Opioid Use

Cited by 444

Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial

Cleeland, C. S., Wang, X. S., Shi, Q., Mendoza, T. R., Wright, S. L., Berry, M. D., Malveaux, D., Shah, P. K., Gning, I., Hofstetter, W. L., et al. (2011) · Journal of Clinical Oncology

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 341

The symptom burden of cancer: Evidence for a core set of cancer‐related and treatment‐related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study

Cleeland, C. S., Zhao, F., Chang, V. T., Sloan, J. A., O'Mara, A. M., Gilman, P. B., Weiss, M., Mendoza, T. R., Lee, J., & Fisch, M. J. (2013) · Cancer

Cancer survivorship and careFrailty in Older Adults

Cited by 316

The Norwegian Brief Pain Inventory Questionnaire

Klepstad, P., Loge, J. H., Borchgrevink, P. C., Mendoza, T. R., Cleeland, C. S., & Kaasa, S. (2002) · Journal of Pain and Symptom Management

Pain Management and Opioid UseCancer survivorship and care

Cited by 313

Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling

Cleeland, C. S., Nakamura, Y., Mendoza, T. R., Edwards, K. R., Douglas, J., & Serlin, R. C. (1996) · Pain

Pain Management and Opioid UseMusculoskeletal pain and rehabilitation

Cited by 255

The Brief Pain Inventory and Its “Pain At Its Worst in the Last 24 Hours” Item: Clinical Trial Endpoint Considerations

Atkinson, T. M., Mendoza, T. R., Sit, L., Passik, S., Scher, H. I., Cleeland, C., & Basch, E. (2010) · Pain Medicine

Pain Management and Opioid UseStatistical Methods in Clinical Trials

Cited by 224

A validation study of an Italian version of the brief pain inventory (Breve questionario per la valutazione del dolore)

Caraceni, A., Mendoza, T. R., Mencaglia, E., Baratella, C., Edwards, K., Forjaz, M. J., Martini, C., Serlin, R. C., de Conno, F., & Cleeland, C. S. (1996) · Pain

Pain Management and Opioid UseCancer survivorship and care

Cited by 203

Validation of the German Version of the Brief Fatigue Inventory

Radbruch, L., Sabatowski, R., Elsner, F., Everts, J., Mendoza, T., & Cleeland, C. (2003) · Journal of Pain and Symptom Management

Cancer survivorship and carePain Management and Opioid Use

Cited by 136

Greek Brief Pain Inventory: Validation and Utility in Cancer Pain

Mystakidou, K., Mendoza, T., Tsilika, E., Befon, S., Parpa, E., Bellos, G., Vlahos, L., & Cleeland, C. (2001) · Oncology

Pain Management and Opioid UsePediatric Pain Management Techniques

Cited by 123

Radiomics to predict immunotherapy-induced pneumonitis: proof of concept

Colen, R. R., Fujii, T., Bilen, M. A., Kotrotsou, A., Abrol, S., Hess, K. R., Hajjar, J., Suarez-Almazor, M. E., Alshawa, A., Hong, D. S., et al. (2018) · Investigational New Drugs

Radiomics and Machine Learning in Medical ImagingCancer Immunotherapy and Biomarkers

Cited by 120

Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial

Shah, J. J., Feng, L., Thomas, S. K., Berkova, Z., Weber, D. M., Wang, M., Qazilbash, M. H., Champlin, R. E., Mendoza, T. R., Cleeland, C., et al. (2016) · Blood Cancer Journal

Multiple Myeloma Research and TreatmentsBone health and treatments

Cited by 35

Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

Lee, M. K., Mitchell, S. A., Basch, E., Mazza, G. L., Langlais, B. T., Thanarajasingam, G., Ginos, B. F., Rogak, L., Meek, E. A., Jansen, J., et al. (2025) · Quality of Life Research

Cancer survivorship and careStatistical Methods in Clinical Trials

Cited by 8